Cargando…

DNA Methylation by Bisulfite Next-Generation Sequencing for MLH1 and MGMT in Oral Squamous Cell Carcinomas and Potentially Malignant Disorders: An Integrative Analysis towards Field Cancerization

Background and Objectives: MGMT methylation is a well-described biomarker in several solid tumors and MLH1 seems to occur in the initial stages of oral carcinogenesis. The aims of this study were to evaluate MHL1 and MGMT methylation levels in oral squamous cell carcinoma (OSCC) and oral potentially...

Descripción completa

Detalles Bibliográficos
Autores principales: Padin-Iruegas, Elena, Chamorro-Petronacci, Cintia M., Sines-Cajade, Iria, Lorenzo-Pouso, Alejandro I., Blanco-Carrión, Andrés, Pérez-Jardón, Alba, Gándara-Vila, Pilar, Pérez-Sayans, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322644/
https://www.ncbi.nlm.nih.gov/pubmed/35888599
http://dx.doi.org/10.3390/medicina58070878
_version_ 1784756355715825664
author Padin-Iruegas, Elena
Chamorro-Petronacci, Cintia M.
Sines-Cajade, Iria
Lorenzo-Pouso, Alejandro I.
Blanco-Carrión, Andrés
Pérez-Jardón, Alba
Gándara-Vila, Pilar
Pérez-Sayans, Mario
author_facet Padin-Iruegas, Elena
Chamorro-Petronacci, Cintia M.
Sines-Cajade, Iria
Lorenzo-Pouso, Alejandro I.
Blanco-Carrión, Andrés
Pérez-Jardón, Alba
Gándara-Vila, Pilar
Pérez-Sayans, Mario
author_sort Padin-Iruegas, Elena
collection PubMed
description Background and Objectives: MGMT methylation is a well-described biomarker in several solid tumors and MLH1 seems to occur in the initial stages of oral carcinogenesis. The aims of this study were to evaluate MHL1 and MGMT methylation levels in oral squamous cell carcinoma (OSCC) and oral potentially malignant disorders (OPMDs), and to integrate this information with The Cancer Genome Atlas (TCGA) database. Materials and Methods: To determine the percentage of gene methylation in MLH1 and MGMT, pyrosequencing analysis was conducted. Samples were divided as follows: (1) patients diagnosed with OSCC (N = 16); (2) patients with OPDM who developed OSCC in the same location (N = 47); and (3) patients with OPDM who developed OSCC in a different location (N = 22). As a validation cohort in this study, data from The Cancer Genomic Atlas (TCGA) database, particularly regarding Head and Neck Squamous Cell Carcinoma, was used. Results: Overall MLH1 methylation levels of 8.6 ± 11.5% and 8.1 ± 9.2% for MGMT were obtained. With regard to MHL1, the OSCC presented the highest degree of methylation with 9.3 ± 7.3% (95%CI 5.1–13.6), and with regards to MGMT, the simultaneous malignancy group presented the highest degree of methylation with 10 ± 13.5% (95%CI 6–10), although no significant differences were found between the groups (p = 0.934 and p = 0.515, respectively). The estimated survival was higher for MGMT methylated cases (19.1 months, 95%CI 19.1–19.1) than for unmethylated cases (9.4 months, 95%CI 6–12.8), but not statistically significant. Conclusions: Our results did not show a correlation between MGMT and MLH1 methylation and any clinicopathological feature or survival in our institutional cohort. MLH1 methylation was present mainly in OSCC, whilst MGMT in OPMD represented a modest contribution to field cancerization, with an overall consistency with the TCGA database.
format Online
Article
Text
id pubmed-9322644
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93226442022-07-27 DNA Methylation by Bisulfite Next-Generation Sequencing for MLH1 and MGMT in Oral Squamous Cell Carcinomas and Potentially Malignant Disorders: An Integrative Analysis towards Field Cancerization Padin-Iruegas, Elena Chamorro-Petronacci, Cintia M. Sines-Cajade, Iria Lorenzo-Pouso, Alejandro I. Blanco-Carrión, Andrés Pérez-Jardón, Alba Gándara-Vila, Pilar Pérez-Sayans, Mario Medicina (Kaunas) Article Background and Objectives: MGMT methylation is a well-described biomarker in several solid tumors and MLH1 seems to occur in the initial stages of oral carcinogenesis. The aims of this study were to evaluate MHL1 and MGMT methylation levels in oral squamous cell carcinoma (OSCC) and oral potentially malignant disorders (OPMDs), and to integrate this information with The Cancer Genome Atlas (TCGA) database. Materials and Methods: To determine the percentage of gene methylation in MLH1 and MGMT, pyrosequencing analysis was conducted. Samples were divided as follows: (1) patients diagnosed with OSCC (N = 16); (2) patients with OPDM who developed OSCC in the same location (N = 47); and (3) patients with OPDM who developed OSCC in a different location (N = 22). As a validation cohort in this study, data from The Cancer Genomic Atlas (TCGA) database, particularly regarding Head and Neck Squamous Cell Carcinoma, was used. Results: Overall MLH1 methylation levels of 8.6 ± 11.5% and 8.1 ± 9.2% for MGMT were obtained. With regard to MHL1, the OSCC presented the highest degree of methylation with 9.3 ± 7.3% (95%CI 5.1–13.6), and with regards to MGMT, the simultaneous malignancy group presented the highest degree of methylation with 10 ± 13.5% (95%CI 6–10), although no significant differences were found between the groups (p = 0.934 and p = 0.515, respectively). The estimated survival was higher for MGMT methylated cases (19.1 months, 95%CI 19.1–19.1) than for unmethylated cases (9.4 months, 95%CI 6–12.8), but not statistically significant. Conclusions: Our results did not show a correlation between MGMT and MLH1 methylation and any clinicopathological feature or survival in our institutional cohort. MLH1 methylation was present mainly in OSCC, whilst MGMT in OPMD represented a modest contribution to field cancerization, with an overall consistency with the TCGA database. MDPI 2022-06-30 /pmc/articles/PMC9322644/ /pubmed/35888599 http://dx.doi.org/10.3390/medicina58070878 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Padin-Iruegas, Elena
Chamorro-Petronacci, Cintia M.
Sines-Cajade, Iria
Lorenzo-Pouso, Alejandro I.
Blanco-Carrión, Andrés
Pérez-Jardón, Alba
Gándara-Vila, Pilar
Pérez-Sayans, Mario
DNA Methylation by Bisulfite Next-Generation Sequencing for MLH1 and MGMT in Oral Squamous Cell Carcinomas and Potentially Malignant Disorders: An Integrative Analysis towards Field Cancerization
title DNA Methylation by Bisulfite Next-Generation Sequencing for MLH1 and MGMT in Oral Squamous Cell Carcinomas and Potentially Malignant Disorders: An Integrative Analysis towards Field Cancerization
title_full DNA Methylation by Bisulfite Next-Generation Sequencing for MLH1 and MGMT in Oral Squamous Cell Carcinomas and Potentially Malignant Disorders: An Integrative Analysis towards Field Cancerization
title_fullStr DNA Methylation by Bisulfite Next-Generation Sequencing for MLH1 and MGMT in Oral Squamous Cell Carcinomas and Potentially Malignant Disorders: An Integrative Analysis towards Field Cancerization
title_full_unstemmed DNA Methylation by Bisulfite Next-Generation Sequencing for MLH1 and MGMT in Oral Squamous Cell Carcinomas and Potentially Malignant Disorders: An Integrative Analysis towards Field Cancerization
title_short DNA Methylation by Bisulfite Next-Generation Sequencing for MLH1 and MGMT in Oral Squamous Cell Carcinomas and Potentially Malignant Disorders: An Integrative Analysis towards Field Cancerization
title_sort dna methylation by bisulfite next-generation sequencing for mlh1 and mgmt in oral squamous cell carcinomas and potentially malignant disorders: an integrative analysis towards field cancerization
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322644/
https://www.ncbi.nlm.nih.gov/pubmed/35888599
http://dx.doi.org/10.3390/medicina58070878
work_keys_str_mv AT padiniruegaselena dnamethylationbybisulfitenextgenerationsequencingformlh1andmgmtinoralsquamouscellcarcinomasandpotentiallymalignantdisordersanintegrativeanalysistowardsfieldcancerization
AT chamorropetronaccicintiam dnamethylationbybisulfitenextgenerationsequencingformlh1andmgmtinoralsquamouscellcarcinomasandpotentiallymalignantdisordersanintegrativeanalysistowardsfieldcancerization
AT sinescajadeiria dnamethylationbybisulfitenextgenerationsequencingformlh1andmgmtinoralsquamouscellcarcinomasandpotentiallymalignantdisordersanintegrativeanalysistowardsfieldcancerization
AT lorenzopousoalejandroi dnamethylationbybisulfitenextgenerationsequencingformlh1andmgmtinoralsquamouscellcarcinomasandpotentiallymalignantdisordersanintegrativeanalysistowardsfieldcancerization
AT blancocarrionandres dnamethylationbybisulfitenextgenerationsequencingformlh1andmgmtinoralsquamouscellcarcinomasandpotentiallymalignantdisordersanintegrativeanalysistowardsfieldcancerization
AT perezjardonalba dnamethylationbybisulfitenextgenerationsequencingformlh1andmgmtinoralsquamouscellcarcinomasandpotentiallymalignantdisordersanintegrativeanalysistowardsfieldcancerization
AT gandaravilapilar dnamethylationbybisulfitenextgenerationsequencingformlh1andmgmtinoralsquamouscellcarcinomasandpotentiallymalignantdisordersanintegrativeanalysistowardsfieldcancerization
AT perezsayansmario dnamethylationbybisulfitenextgenerationsequencingformlh1andmgmtinoralsquamouscellcarcinomasandpotentiallymalignantdisordersanintegrativeanalysistowardsfieldcancerization